FDA Re-Examining Citizen Petition Process To Speed Generic Approvals

FDA is taking another look at its citizen petition review process in an attempt to expedite decisions on generic drug applications, Center for Drug Evaluation & Research Acting Director Steven Galson told the Generic Pharmaceutical Association's annual meeting Feb. 25 in Boca Raton, Fla